Holen Sie sich die Stockscreener-App
0.6108
5.13%
-0.033
Handel nachbörslich:
.60
-0.0108
-1.77%
Schlusskurs vom Vortag:
$0.6438
Offen:
$0.6538
24-Stunden-Volumen:
1.40M
Relative Volume:
1.63
Marktkapitalisierung:
$60.32M
Einnahmen:
$322.20M
Nettoeinkommen (Verlust:
$-196.37M
KGV:
-0.3288
EPS:
-1.8575
Netto-Cashflow:
$27.02M
1W Leistung:
-11.13%
1M Leistung:
-15.15%
6M Leistung:
-56.06%
1J Leistung:
-78.34%
1-Tages-Spanne:
$0.5879
$0.68
1-Wochen-Bereich:
$0.5879
$0.71
52-Wochen-Spanne:
$0.5879
$2.815
Docgo Inc Stock (DCGO) Company Profile
Firmenname
Docgo Inc
Sektor
Branche
Telefon
(844) 443-6246
Adresse
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
0.6108 | 63.58M | 322.20M | -196.37M | 27.02M | -1.8575 |
HCA
Hca Healthcare Inc
|
484.02 | 108.59B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.04 | 17.36B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.26 | 12.31B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
203.89 | 11.79B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
186.72 | 11.36B | 17.36B | 1.51B | 849.25M | 23.15 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-08-18 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-01-19 | Eingeleitet | Stifel | Buy |
| 2021-12-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Docgo Inc Aktie (DCGO) Neueste Nachrichten
DocGo (NASDAQ:DCGO) Given New $1.00 Price Target at Canaccord Genuity Group - MarketBeat
Canaccord cuts DocGo stock price target on profitability concerns - Investing.com
Analyst Calls: Can DocGo Inc ride the EV wave2026 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
DocGo Inc. (NASDAQ:DCGO) Q4 2025 earnings call transcript - MSN
Aug Action: What are DocGo Incs recent SEC filings showingPortfolio Profit Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT) - The Globe and Mail
Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies® - The Joplin Globe
Healthcare provider DocGo joins 2026 World's Most Ethical Companies list - Stock Titan
DocGo Earnings Call Signals Turnaround Amid Cash Strain - TipRanks
DocGo Inc. (DCGO) reports Q4 loss, beats revenue estimates - MSN
Stifel cuts DocGo stock price target on transition year outlook By Investing.com - Investing.com India
Cantor Fitzgerald reiterates DocGo stock rating on 2026 outlook By Investing.com - Investing.com India
DocGo (NASDAQ:DCGO) Price Target Cut to $2.50 by Analysts at Stifel Nicolaus - MarketBeat
Cantor Fitzgerald reiterates DocGo stock rating on 2026 outlook - Investing.com
Stifel cuts DocGo stock price target on transition year outlook - Investing.com
DocGo (NASDAQ:DCGO) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
DocGo (NASDAQ:DCGO) Given "Buy" Rating at Needham & Company LLC - MarketBeat
DocGo Inc. (NASDAQ:DCGO) Q4 2025 Earnings Call Transcript - Insider Monkey
DocGo outlines 2026 revenue guidance of $290M–$310M as company targets profitability and explores strategic alternatives - MSN
DocGo Inc. 2025 Annual Report: Mobile Health Services, Business Strategy, Key Risks, and Corporate Overview - Minichart
DocGo Inc (DCGO) Q4 2025 Earnings Call Highlights: Revenue Surpasses Expectations Amid ... By GuruFocus - Investing.com Canada
DCGO SEC FilingsDOCGO INC 10-K, 10-Q, 8-K Forms - Stock Titan
DocGo (DCGO) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
DocGo Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: DocGo’s Q4 2025 results miss EPS but beat revenue - Investing.com South Africa
DocGo Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DocGo Inc. (DCGO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
DocGo Q4 2025 Earnings Call: Financial Results & Forward-Looking StatementsNews and Statistics - IndexBox
DCGO: 2026 guidance raised on strong SteadyMD and transport growth, with profitability expected in H2 - TradingView
DocGo Q4 Earnings Call Highlights - MarketBeat
DocGo (DCGO) Q4 2025 Earnings Call Transcript - AOL.com
DocGo earnings missed by $1.23, revenue topped estimates - Investing.com Canada
DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
DocGo (NASDAQ:DCGO) Announces Quarterly Earnings Results - MarketBeat
DOCGO ($DCGO) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Mobile healthcare service provider DocGo Inc has announced the official launch of a strategic review process aimed at exploring various strategic alternatives to maximize shareholder value. - Bitget
[10-K] DocGo Inc. Files Annual Report | DCGO SEC FilingForm 10-K - Stock Titan
DocGo shares surge 15% on Q4 revenue beat and raised guidance - Investing.com India
DocGo (NASDAQ: DCGO) swings to 2025 loss but raises 2026 outlook - Stock Titan
BRIEF-DocGo Q4 Revenue USD 74.9 Million Vs. IBES Estimate USD 70.4 Million - TradingView
DocGo Announces Fourth Quarter and Full Year 2025 Results - The Joplin Globe
DocGo Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
DocGo Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
What To Expect From DocGo Inc (DCGO) Q4 2025 Earnings - GuruFocus
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Sahm
Former DocGo CEO faces foreclosure on Flatiron condo - Crain's New York
DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
DocGo Conference: CEO Maps “Healthcare at Any Address” as Company Targets $280M-$300M 2026 Revenue - MarketBeat
Finanzdaten der Docgo Inc-Aktie (DCGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
3.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):